Rinatabart Sesutecan For Patients With Heavily Pretreated Ovarian Or Endometrial Cancer: Results From The Dose Escalation Cohort Of A Phase 1/2 Study
Publication Title
European Congress on Gynaecological Oncology (ESGO 2025)
Document Type
Abstract
Publication Date
11-1-2024
Keywords
california; santa rosa
Area of Special Interest
Cancer
Area of Special Interest
Women & Children
Specialty/Research Institute
Oncology
Specialty/Research Institute
Obstetrics & Gynecology
Comments
Justin Call1, Oladapo Yeku2, Erika Hamilton3, Jian Zhang4, Gottfried Konecny5, Ian Anderson6, Ira Winer7, Debra Richardson8, Edward Kavalerchik9, Michael Gillespie9, Elizabeth K. Lee10